N/A N=51 Kidney and Periodontal Disease Study
Chronic Kidney Disease · Periodontal Disease
Primary: Number of Participants Completing Study Protocol — 17; 34; 14; 30 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=130 MEmbranous Nephropathy Trial Of Rituximab
Idiopathic Membranous Nephropathy
Primary: Remission Status — 39; 13 Participants — p=0.001
Phase 2 N=17 Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
Insulin Resistance
Primary: Glucose — 7.1; 6.4 mmol/L
Phase 2 N=59 Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias
Premature Atrial Contraction
Primary: Change in Premature Atrial Contractions (PACs) — -0.6; -5.6 Episodes/hour
N/A N=1 Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
Traumatic Brain Injury · Multiple Sclerosis · Alzheimer's Disease
Primary: Regional Cerebral Blood Flow Values of the Brain Measured Using Pseudo-continuous Arterial Spin Labeling (pCASL) MRI. — 35.4 ml/100g/min
Phase 2 N=53 Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
Renal Cell Carcinoma
Primary: The Sensitivity of Detecting RCC Recurrence (Using Contrast-enhanced MRI as a Reference Standard) on a Single Contrast-enhanced Ultrasound Exam. — 100 percent of patients
Phase 3 N=106 A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Narcolepsy With Cataplexy
Primary: Change in Weekly Number of Cataplexy Attacks — 0.27; 12.71 number of attacks
Phase 2 N=341 Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Streptococcus Pneumoniae Infection · Pneumococcal Infections
Primary: Percentage of Adult Participants Experiencing ≥1 Adverse Event (AE) — 100.0; 100.0 Percentage of Participants
N/A N=28,291 Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ
Ductal Carcinoma In Situ
Primary: Side Effects (Claim-based Measure), Including Lymphedema, Seroma, Wound Infection, or Pain — 534; 404; 23; 60 Participants — p=<.001
N/A N=52 Home Study of an Advanced Upper Limb Prosthesis
Traumatic Amputation of Arm
Primary: Change in Quality of Life (QOL) Scale — 5.8; 5.3 score on a scale — p=.9358
N/A N=159 A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery
Breast Cancer
Primary: The Mean Distance Between the Image-defined and Palpation-defined Edges of the Tumor. — 7.2 mm
N/A N=90 Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction
Breast Cancer
Primary: Number of Participants With Complications After Tissue Expander Replacement With Implant — 10; 10 participants
Phase 3 N=66 Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women
Diabetes Prevention in Women After GDM Who Are at High-risk
Primary: Change in Body Weight — -21.5; -12.5; -4.4 kilograms — p=<0.032
Phase 2 N=25 Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions
Lung Cancer
Primary: Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 — 1 Participants
N/A N=198 Group Treatment for PTSD: A Randomized Clinical Trial With Veterans
PTSD
Primary: Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) — 28.76; 31.87 units on a scale